Success Metrics

Clinical Success Rate
85.7%

Based on 6 completed trials

Completion Rate
86%(6/7)
Active Trials
1(9%)
Results Posted
17%(1 trials)
Terminated
1(9%)

Phase Distribution

Ph phase_2
3
27%
Ph not_applicable
7
64%
Ph phase_4
1
9%

Phase Distribution

0

Early Stage

3

Mid Stage

1

Late Stage

Phase Distribution11 total trials
Phase 2Efficacy & side effects
3(27.3%)
Phase 4Post-market surveillance
1(9.1%)
N/ANon-phased studies
7(63.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

85.7%

6 of 7 finished

Non-Completion Rate

14.3%

1 ended early

Currently Active

1

trials recruiting

Total Trials

11

all time

Status Distribution
Active(1)
Completed(6)
Terminated(1)
Other(3)

Detailed Status

Completed6
unknown3
Recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
1
Success Rate
85.7%
Most Advanced
Phase 4

Trials by Phase

Phase 23 (27.3%)
Phase 41 (9.1%)
N/A7 (63.6%)

Trials by Status

completed655%
unknown327%
recruiting19%
terminated19%

Recent Activity

1 active trials
Showing 5 of 11
recruitingnot_applicable

AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions

NCT06959524
completednot_applicable

CVT-ISR First in Human Trial for Coronary In-Stent Restenosis

NCT05731700
unknownnot_applicable

Post-marketing Study in Femoral Popliteal Artery of Drug Coated Balloon Used for Treatment of Lower Limb Ischemia

NCT05498740
unknownnot_applicable

A Trail of Drug-coated Balloon Treating Below The Knee Arterial Diseases

NCT05415995
completednot_applicable

Basel Stent Kosten Effektivitäts Trial Drug Eluting Balloons vs. Drug Eluting Stents in Small Vessel Interventions

NCT01574534
View all 11 trials

Clinical Trials (11)

Showing 11 of 11 trials
NCT06959524Not Applicable

AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions

Recruiting
NCT05731700Not Applicable

CVT-ISR First in Human Trial for Coronary In-Stent Restenosis

Completed
NCT05498740Not Applicable

Post-marketing Study in Femoral Popliteal Artery of Drug Coated Balloon Used for Treatment of Lower Limb Ischemia

Unknown
NCT05415995Not Applicable

A Trail of Drug-coated Balloon Treating Below The Knee Arterial Diseases

Unknown
NCT01574534Not Applicable

Basel Stent Kosten Effektivitäts Trial Drug Eluting Balloons vs. Drug Eluting Stents in Small Vessel Interventions

Completed
NCT00856765Phase 2

Drug-eluting Balloon in Acute Myocardial Infarction

Completed
NCT00540813Not Applicable

Paclitaxel-Eluting Balloon Angioplasty and Coroflex™-Stents in the Treatment of Bifurcated Coronary Lesions

Completed
NCT02632955Not Applicable

Drug Eluting Balloon for Early Fistula Failure Trial

Unknown
NCT00857441Phase 2

Drug-eluting Balloon in Bifurcations Trial

Completed
NCT00404144Phase 2

PEPCAD I. The Paclitaxel-Eluting PTCA-Balloon Catheter to Treat Small Vessel

Completed
NCT01899235Phase 4

The Treatment of Coronary De-novo Lesions With the Elutax Paclitaxel-eluting Balloon Alone, a Pilot Study

Terminated

All 11 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
11